Citation Impact

Citing Papers

Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Contributing Knowledge to Electronic Knowledge Repositories: An Empirical Investigation1
2005 Standout
Head and neck squamous cell carcinoma
2020 Standout
Molecular biology of squamous cell carcinoma of the head and neck
2006
Frailty Consensus: A Call to Action
2013 Standout
Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)
2014 Standout
The scent of disease: volatile organic compounds of the human body related to disease and disorder
2011 Standout
Sarcopenia: a chronic complication of type 2 diabetes mellitus
2018 Standout
Head and neck cancer
2008 Standout
Cancer Chemoprevention: Progress and Promise
1998
EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer
2000
Comparisons of Sarcopenia Defined by IWGS and EWGSOP Criteria Among Older People: Results From the I-Lan Longitudinal Aging Study
2013
The molecular biology of head and neck cancer
2010 Standout
Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination Survey
2014
Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions
2002
Expanding fields of genetically altered cells in head and neck squamous carcinogenesis
2004
The convergence of cancer prevention and therapy in early-phase clinical drug development
2004
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Apigenin: A Promising Molecule for Cancer Prevention
2010 Standout
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
2001
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group
2013 Standout
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
2005
Epidemiology, Staging, and Screening of Head and Neck Cancer
2006
Sarcopenia
2019 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Is the Optimal Level of Protein Intake for Older Adults Greater Than the Recommended Dietary Allowance?
2012
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Head and Neck Cancer
2001 Standout
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
2001 Standout
Effects of extrinsic and intrinsic motivation on employee knowledge sharing intentions
2007 Standout
Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.
1999
Worldwide burden of cancer attributable to HPV by site, country and HPV type
2017 Standout
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
2008
No evidence for active human papillomavirus (HPV) in fields surrounding HPV‐positive oropharyngeal tumors
2013
Cancer prevention science and practice.
2002
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Methods, Diagnostic Criteria, Cutoff Points, and Prevalence of Sarcopenia among Older People
2014
On Organizational Becoming: Rethinking Organizational Change
2002 Standout
Does Histologic Grade Have a Role in the Management of Head and Neck Cancers?
2001
Cracking the code of change.
2001
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Chemical Glycoproteomics
2016 StandoutNobel

Works of Dae‐Jin Lee being referenced

Distinguishing Second Primary Tumors From Lung Metastases in Patients With Head and Neck Sauamous Cell Carcinoma
1998
Prevalence of Sarcopenia and Sarcopenic Obesity in the Korean Population Based on the Fourth Korean National Health and Nutritional Examination Surveys
2012
Rankless by CCL
2026